Sarepta Therapeutics, Inc. SEC filings SRPT

Sarepta Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Mar 31, 2011. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (material agreement). The company's fiscal year ends on December 31.

Sarepta Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Sep 23, 2026 Sep 23, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
S-8 Employee stock plan registration Jul 28, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 27, 2026 Jul 23, 2026
S-8 Employee stock plan registration Jun 4, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 4, 2026 Jun 4, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 4, 2026
10-K Annual report Mar 2, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Feb 25, 2026 Feb 25, 2026
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 12, 2026
8-K Current report
Material agreement, New debt
Dec 19, 2025 Dec 18, 2025
8-K Current report
Unregistered share sale, Other events
Dec 11, 2025 Dec 10, 2025
8-K Current report
Officer or director change
Dec 8, 2025 Dec 7, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
8-K Current report
Material agreement, New debt, Other events
Aug 29, 2025 Aug 28, 2025
8-K Current report
Unregistered share sale
Aug 21, 2025 Aug 18, 2025
8-K Current report
Officer or director change
Aug 13, 2025 Aug 12, 2025
S-8 Employee stock plan registration Aug 6, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Other events
Jul 21, 2025 Jul 21, 2025
8-K Current report
Results of operations, Exit or restructuring costs, Officer or director change
Jul 16, 2025 Jul 14, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 6, 2025 Jun 5, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 5, 2025
S-3ASR Automatic shelf registration Mar 3, 2025 —
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
8-K Current report
Material agreement, New debt
Feb 14, 2025 Feb 13, 2025
8-K Current report
Results of operations
Jan 13, 2025 Jan 13, 2025
8-K Current report
Material agreement
Nov 26, 2024 Nov 24, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change
Sep 16, 2024 Sep 12, 2024
S-8 Employee stock plan registration Aug 7, 2024 —
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 7, 2024 Jun 6, 2024
10-Q Quarterly report May 1, 2024 Mar 31, 2024
DEF 14A Proxy statement Apr 24, 2024 Jun 6, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 24, 2024 —
S-8 POS Filing Mar 28, 2024 —
S-8 POS Filing Mar 28, 2024 —
S-8 POS Filing Mar 28, 2024 —
S-8 POS Filing Mar 28, 2024 —
10-K Annual report Feb 28, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
10-Q Quarterly report Nov 1, 2023 Sep 30, 2023
S-8 Employee stock plan registration Aug 2, 2023 —
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Regulation FD disclosure
Jun 22, 2023 Jun 22, 2023
8-K Current report
Regulation FD disclosure
Jun 22, 2023 Jun 22, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 9, 2023 Jun 8, 2023
10-Q Quarterly report May 2, 2023 Mar 31, 2023
DEFA14A Additional proxy material Apr 24, 2023 —
ARS Annual report to shareholders Apr 24, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 24, 2023 —
8-K Current report
Material agreement, Unregistered share sale
Mar 3, 2023 Mar 2, 2023
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
8-K Current report
Bylaw or fiscal year change
Dec 13, 2022 Dec 9, 2022
8-K Current report
Officer or director change
Nov 2, 2022 Oct 31, 2022
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Other events
Sep 19, 2022 Sep 13, 2022
S-8 Employee stock plan registration Aug 2, 2022 —
10-Q Quarterly report Aug 2, 2022 Jun 30, 2022
8-K Current report
Officer or director change, Shareholder vote results
Jun 3, 2022 Jun 2, 2022
10-Q Quarterly report May 4, 2022 Mar 31, 2022
DEF 14A Proxy statement Apr 25, 2022 Jun 2, 2022
8-K Current report
Officer or director change
Apr 21, 2022 Apr 19, 2022
8-K Current report
Officer or director change
Apr 5, 2022 Mar 31, 2022
S-3ASR Automatic shelf registration Mar 2, 2022 —
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Officer or director change
Nov 17, 2021 Nov 15, 2021
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
8-K Current report
Material agreement, Results of operations, Other events
Oct 15, 2021 Oct 12, 2021
424B5 Prospectus supplement Oct 15, 2021 —
424B5 Prospectus supplement Oct 12, 2021 —
8-K Current report
Regulation FD disclosure
Sep 27, 2021 Sep 27, 2021
10-Q Quarterly report Aug 4, 2021 Jun 30, 2021
8-K Current report
Shareholder vote results
Jun 3, 2021 Jun 3, 2021
8-K Current report
Regulation FD disclosure
May 18, 2021 May 18, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Regulation FD disclosure
May 3, 2021 May 3, 2021
DEFA14A Additional proxy material Apr 20, 2021 —
DEF 14A Proxy statement Apr 20, 2021 Jun 3, 2021
10-K Annual report Mar 1, 2021 Dec 31, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
8-K Current report
Regulation FD disclosure
Jan 7, 2021 Jan 7, 2021
8-K Current report
Officer or director change
Dec 14, 2020 Dec 8, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Material agreement, New debt
Sep 25, 2020 Sep 24, 2020
8-K Current report
Regulation FD disclosure
Sep 9, 2020 Sep 9, 2020
S-8 Employee stock plan registration Aug 5, 2020 —
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Officer or director change
Aug 5, 2020 Aug 3, 2020
8-K Current report
Officer or director change
Jun 30, 2020 Jun 26, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 8, 2020 Jun 4, 2020
8-K Current report
Regulation FD disclosure
Jun 8, 2020 Jun 8, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
DEFA14A Additional proxy material Apr 21, 2020 —
DEF 14A Proxy statement Apr 21, 2020 Jun 4, 2020
UPLOAD Letter from the SEC Apr 16, 2020 —
CORRESP Letter to the SEC Apr 15, 2020 —
UPLOAD Letter from the SEC Apr 13, 2020 —
PRE 14A Preliminary proxy statement Apr 8, 2020 Jun 4, 2020
8-K Current report
Officer or director change
Mar 19, 2020 Mar 18, 2020
D Filing Feb 28, 2020 —
10-K Annual report Feb 26, 2020 Dec 31, 2019
8-K Current report
Officer or director change
Feb 21, 2020 Feb 19, 2020
8-K Current report
Other events
Feb 18, 2020 Feb 14, 2020
8-K Current report
Regulation FD disclosure
Jan 13, 2020 Jan 13, 2020
8-K Current report
Results of operations, Officer or director change, Bylaw or fiscal year change
Jan 13, 2020 Jan 8, 2020
8-K Current report
Material agreement, Unregistered share sale
Dec 23, 2019 Dec 21, 2019
8-K Current report
Material agreement, New debt, Other events
Dec 13, 2019 Dec 12, 2019
D Filing Nov 25, 2019 —
S-3ASR Automatic shelf registration Nov 14, 2019 —
10-Q Quarterly report Nov 7, 2019 Sep 30, 2019
8-K Current report
Regulation FD disclosure
Oct 4, 2019 Oct 4, 2019
S-8 Employee stock plan registration Sep 11, 2019 —
8-K Current report
Regulation FD disclosure
Aug 20, 2019 Aug 19, 2019
8-K Current report
Regulation FD disclosure
Aug 8, 2019 Aug 8, 2019
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Shareholder vote results
Jun 7, 2019 Jun 6, 2019
10-Q Quarterly report May 8, 2019 Mar 31, 2019
DEFA14A Additional proxy material Apr 26, 2019 —
DEF 14A Proxy statement Apr 26, 2019 Jun 6, 2019
8-K Current report
Other events
Apr 5, 2019 Apr 4, 2019
8-K Current report
Regulation FD disclosure
Mar 28, 2019 Mar 28, 2019
8-K Current report
Regulation FD disclosure
Mar 25, 2019 Mar 25, 2019
8-K Current report
Regulation FD disclosure
Mar 25, 2019 Mar 25, 2019
424B5 Prospectus supplement Mar 7, 2019 —
8-K Current report
Material agreement, Other events
Mar 7, 2019 Mar 5, 2019
8-K Current report
Officer or director change
Mar 5, 2019 Mar 5, 2019
424B5 Prospectus supplement Mar 5, 2019 —
S-3ASR Automatic shelf registration Feb 28, 2019 —
10-K Annual report Feb 28, 2019 Dec 31, 2018
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Feb 27, 2019 Feb 27, 2019
8-K Current report
Other events
Feb 14, 2019 Feb 14, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Jan 7, 2019 Jan 7, 2019
8-K Current report
Other events
Dec 20, 2018 Dec 20, 2018
8-K Current report
Officer or director change
Dec 11, 2018 Dec 10, 2018
S-8 Employee stock plan registration Dec 7, 2018 —
8-K Current report
Material agreement, Other events
Nov 9, 2018 Nov 7, 2018
424B5 Prospectus supplement Nov 9, 2018 —
CT ORDER Filing Nov 9, 2018 —
424B5 Prospectus supplement Nov 8, 2018 —
10-Q/A Amended quarterly report Oct 31, 2018 Jun 30, 2018
10-Q Quarterly report Oct 31, 2018 Sep 30, 2018
8-K Current report
Other events
Oct 24, 2018 Oct 24, 2018
8-K Current report
Regulation FD disclosure
Oct 3, 2018 Oct 3, 2018
8-K Current report
Other events
Sep 24, 2018 Sep 24, 2018
8-K Current report
Other events
Sep 21, 2018 Sep 21, 2018
10-Q Quarterly report Aug 8, 2018 Jun 30, 2018
8-K Current report
Officer or director change
Aug 1, 2018 Jul 26, 2018
8-K Current report
Other events
Jul 26, 2018 Jul 25, 2018
8-K Current report
Officer or director change
Jun 27, 2018 Jun 26, 2018
8-K Current report
Regulation FD disclosure
Jun 19, 2018 Jun 19, 2018
8-K Current report
Shareholder vote results
Jun 6, 2018 Jun 6, 2018
8-K Current report
Regulation FD disclosure
May 3, 2018 May 3, 2018
10-Q Quarterly report May 3, 2018 Mar 31, 2018
DEFA14A Additional proxy material Apr 26, 2018 —
DEF 14A Proxy statement Apr 26, 2018 Jun 6, 2018
8-K Current report
Other events
Mar 12, 2018 Mar 12, 2018
10-K Annual report Mar 1, 2018 Dec 31, 2017
8-K Current report
Other events
Mar 1, 2018 Mar 1, 2018
8-K Current report
Results of operations, Regulation FD disclosure
Jan 8, 2018 Jan 8, 2018
8-K Current report
Officer or director change
Dec 5, 2017 Dec 5, 2017
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Nov 14, 2017 Nov 7, 2017
S-8 Employee stock plan registration Nov 1, 2017 —
10-Q Quarterly report Nov 1, 2017 Sep 30, 2017
8-K Current report
Other events
Oct 25, 2017 Oct 25, 2017
CT ORDER Filing Sep 12, 2017 —
8-K Current report
Officer or director change
Aug 17, 2017 Aug 17, 2017
10-Q Quarterly report Aug 3, 2017 Jun 30, 2017
8-K Current report
Material agreement, Other events
Jul 26, 2017 Jul 24, 2017
424B5 Prospectus supplement Jul 25, 2017 —
424B5 Prospectus supplement Jul 24, 2017 —
8-K Current report
Results of operations
Jul 19, 2017 Jul 19, 2017
8-K Current report
Material agreement, New debt, Other events
Jul 18, 2017 Jul 18, 2017
8-K Current report
Material agreement, Other events
Jul 18, 2017 Jul 17, 2017
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 28, 2017 Jun 26, 2017
8-K Current report
Shareholder vote results, Other events
Jun 8, 2017 Jun 6, 2017
10-Q Quarterly report May 4, 2017 Mar 31, 2017
8-K Current report
Officer or director change
Apr 27, 2017 Apr 24, 2017
DEFA14A Additional proxy material Apr 27, 2017 —
DEF 14A Proxy statement Apr 27, 2017 Jun 6, 2017
8-K Current report
Results of operations
Apr 27, 2017 Apr 27, 2017
8-K Current report
Acquisition or sale of assets
Mar 31, 2017 Mar 31, 2017
8-K Current report
Results of operations
Feb 28, 2017 Feb 28, 2017
10-K Annual report Feb 28, 2017 Dec 31, 2016
8-K Current report
Material agreement
Feb 21, 2017 Feb 20, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SRPT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Large accelerated filer
SEC CIK
873303
Former names
Sarepta Therapeutics, Inc. (until Sep 23, 2026); AVI BIOPHARMA INC (until Jul 12, 2012); ANTIVIRALS INC (until May 12, 1998)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.